CN109953348A - A kind of collagen protein powder to conduce to sleep - Google Patents
A kind of collagen protein powder to conduce to sleep Download PDFInfo
- Publication number
- CN109953348A CN109953348A CN201711403990.3A CN201711403990A CN109953348A CN 109953348 A CN109953348 A CN 109953348A CN 201711403990 A CN201711403990 A CN 201711403990A CN 109953348 A CN109953348 A CN 109953348A
- Authority
- CN
- China
- Prior art keywords
- sleep
- protein powder
- collagen protein
- conduce
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 25
- 108010035532 Collagen Proteins 0.000 title claims abstract description 25
- 239000000843 powder Substances 0.000 title claims abstract description 25
- 240000008866 Ziziphus nummularia Species 0.000 claims abstract description 9
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 241001247821 Ziziphus Species 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 3
- 208000019901 Anxiety disease Diseases 0.000 abstract description 4
- 230000036506 anxiety Effects 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract description 2
- 206010039897 Sedation Diseases 0.000 abstract description 2
- 230000000049 anti-anxiety effect Effects 0.000 abstract description 2
- 239000002249 anxiolytic agent Substances 0.000 abstract description 2
- 208000010643 digestive system disease Diseases 0.000 abstract description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 abstract description 2
- 230000001537 neural effect Effects 0.000 abstract description 2
- 230000036280 sedation Effects 0.000 abstract description 2
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 15
- 206010022437 insomnia Diseases 0.000 description 15
- 239000003814 drug Substances 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 2
- 208000010340 Sleep Deprivation Diseases 0.000 description 2
- 229940049706 benzodiazepine Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- 208000022925 sleep disturbance Diseases 0.000 description 2
- 230000002557 soporific effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
Abstract
It the invention discloses a kind of collagen protein powder to conduce to sleep, is formed by following raw materials according mixture: r- aminobutyric acid 0.1g~10g, muzao jujube extract 0.1g~12g, Wild jujube seeds extract 0.1g~12g, vitamin B2100ug~10mg and collagen protein powder 99.6999g~65.99g.Collagen protein powder of the present invention can reduce neuronal activity, and anxiety information is inhibited to be passed to mesencephalic centre, calm nerve and antianxiety, have stable spirit, sedation, can significantly improve sleep quality, it is edible to be particularly suitable for sleep state gastrointestinal disease patient.
Description
Technical field
The present invention relates to field of health care food, in particular it relates to a kind of collagen protein powder to conduce to sleep.
Background technique
Sleep as process necessary to life, be body restore, the important link of integration and consolidating memory, be health not
The component part that can lack.Insomnia refers to sleep or maintenance dyscoimesis, or because of sleep disturbance so that people feel after waking up
Sleep insufficiency.Insomnia is not disease, but a multifactor caused syndrome.Regardless of young people or the elderly may occur in which
Insomnia, often occurs together in the disturbance of emotion such as excitement, anxiety, depression or fear.
Chinese medicine thinks, the sleep and awakening phenomenon of human body " then sleep at nightfall, enter daytime then awake ", be human body reform of nature circle round the clock
A kind of physiological function of self-control of the rhythm and pace of moving things shows.Who can not be violated this rule, " then giving birth to along it, inverse it is then done harm to ".It is existing
For sleep medicine the study found that the sleeping disorders as caused by physiology, psychology, spirit, personality and social factor up to nearly 90
Kind, the heart, diabetes, obesity, immunity degradation, suffers from risk of cancer etc. and has close connection with sleeping disorders cerebrovascular disease
System.
Latest survey is shown: China have 38.2% adult insomniac or have sleeping problems (China Sleep Research Association,
2012 World Sleep Day Global Healths sleep summit forum), wherein 60% or more is women, crowd's twenty percent more than male of having a sleepless night.
Only Shanghai just has 7,000,000 people with insomnia.The whole nation has more than 100,000,000 people with insomnia.The U.S. has 60,000,000 people insomniac, by
Economic loss caused by this is up to 63,000,000,000 dollars every year, and the expense for the treatment of of insomnia patients is 10.9 hundred million dollars every year.
To arouse the whole people to the understanding of sleep importance, 2001, international mental hygiene and Neuscience foundation were sponsored
The whole world sleep and health plan initiated a global activity, by first day of the annual early spring, i.e. March 21 was set to
" World Sleep Day ".This is movable to focus on the concern for causing people to sleep importance and sleep quality.In 2003
" World Sleep Day " can formally be introduced China by state's sleep study.But with the fast development and rhythm of life of China's economic
Quickening, the aggravation of social competition, people also increase in psychology, the pressure in life and work.By these pressure institutes
Caused by insomnia phenomenon also grow in intensity.
Insomnia is very big to the negative effect of quality of life.Chronic insomnia can bring all various worries to people: such as white
It has dizzy spells, is out of strength, is dizzy, amnesia, absent minded, dysphoria, or even multi-organ function disorder occurs, reduces machine
The problem of body immunity function, the spirit aspect such as some appearance depression and anxiety, psychological pressure increases, or even generates the thought committed suicide.
Due to sleep insufficiency, spiritual physically-draining, working efficiency is low, error-prone in work.Serious person, which has to stop working, to come
It cures the disease.Statistics show the U.S. have 60,000,000 people insomnia, therefrom caused by economic loss every year be up to 63,000,000,000 dollars.
China has more than 100,000,000 people to have a sleepless night, therefrom caused by economic loss as one can imagine.
Currently, doctor trained in Western medicine mostly uses greatly calming soporific class drug to the treatment of insomnia.In past 40 years, insomnia is controlled
It treats from barbiturate and develops to current clinically widely used benzodiazepine somnifacient, it compares instead of bar at present
Appropriate class drug.But it takes benzodiazepine somnifacient for a long time and dizzy, headache, drowsiness, in a trance, depressed, Nausea and vomiting, abdomen easily occurs
Rush down or constipation, dysuria, dream, sexual desire reduces and the side effect of ataxia etc., even result in dependence.
In China, the drug for the treatment of insomnia is other than Western medicine, and there are also the drugs for wanting ingredient mainly based on the traditional Chinese medicine.Such as sweet dreams capsule
Deng.Although Chinese medicine has long usage history in China, since its ingredient is many and diverse, it is difficult to be isolated and purified with modern science means
Its effective component, the mechanism of action is unclear, and clinical effectiveness exists uncertain.
Therefore, before researching and developing a kind of drug substitute that is all natural, without side-effects, improving sleep and having wide market
Scape.
Summary of the invention
The purpose of the present invention is to provide a kind of with the collagen to conduce to sleep for having tranquilizing soporific, antitoxic heart-soothing and sedative effect
Albumen powder, the collagen protein powder provided by the present invention to conduce to sleep, remission effect is significant, safe and free of toxic and side effects, and
Has the function of beautifying face and moistering lotion to patient.
In order to solve the above technical problems, a kind of collagen protein powder to conduce to sleep of the invention is by following raw materials according mixture
It forms: r- aminobutyric acid 0.1g~10g, muzao jujube extract 0.1g~12g, Wild jujube seeds extract 0.1g~12g, vitamin
B2100ug~10mg and collagen protein powder 99.6999g~65.99g.
A kind of above-mentioned collagen protein powder to conduce to sleep, the weight of each raw material are as follows: the r- that weight content is 20%
Wild jujube seeds extract 0.8g that muzao jujube extract 0.8g that aminobutyric acid 1g, weight content are 10%, weight content are 10%, dimension
Raw element B25mg and collagen protein powder 97.4g.
For the present invention due to using above-mentioned formula, r- aminobutyric acid (CABA) therein is the inhibition of central nervous system
Mediator is one of most important neurotransmitter in brain tissue, it can reduce neuronal activity, and anxiety information is inhibited to be passed in brain
Pivot, calm nerve and antianxiety have stable spirit, sedation, can improve nerve gastrointestinal dysfunction, sleep disturbance,
The symptoms such as self-disciplining nervous disorder.Muzao jujube tonifying spleen and stomach, tranquilizing mind, adjusts nutrition and pharmacological property at replenishing qi and blood, cures mainly weakness of the spleen and the stomach, qi and blood
Deficiency, deficiency of food, loose stool, fatigue and weakness, palpitation and insomnia, hysteria of womam are disharmony between ying and wei.Semen ziziphi spinosae has central inhibitory action, calm
Hypnosis, calming the heart and calming the nerves, nourishing the liver, arrest sweating.Vitamin B2Sleep quality can be significantly improved.Thus, the present invention can be efficiently solved and be led
The three big causes of disease such as " physical reason " of induced insomnia, " physiological reason ", " spiritual reason ", are a kind of nourishing sexual function collagens
It is edible to be particularly suitable for sleep state gastrointestinal disease patient for powder.
Specific embodiment
Embodiment one: a kind of collagen protein powder to conduce to sleep, in terms of 100g, it is formed by following raw materials according mixture:
R- aminobutyric acid (20%) 1g
Muzao jujube extract (10%) 0.8g
Wild jujube seeds extract (10%) 0.8g
Vitamin B25mg
Collagen protein powder 97.4g
Above-mentioned degree is weight content (similarly hereinafter).It is made into the amount of rear collagen protein powder: 2 times a day, often
Secondary 25g, it is i.e. drinkable after taking appropriate warm water to reconstitute uniformly.
Product specification: 400g/ tank or 25g/ bags
Shelf-life: 24 months
Storage practice: sealing is set and is saved at shady and cool drying
Collagen protein powder product of the present invention are unable to alternatives to medication, and it is edible to be not suitable for children.
Embodiment two: a kind of collagen protein powder to conduce to sleep, in terms of 100g, it is formed by following raw materials according mixture:
R- aminobutyric acid (35%) 0.5g
Muzao jujube extract (10%) 10g
Wild jujube seeds extract (10%) 1g
Vitamin B21mg
Collagen protein powder 84.499g
Embodiment three: a kind of collagen protein powder to conduce to sleep, in terms of 100g, it is formed by following raw materials according mixture:
R- aminobutyric acid (45%) 8g
Muzao jujube extract (10%) 3g
Wild jujube seeds extract (10%) 10g
Vitamin B210mg
Collagen protein powder 78.999g.
Claims (2)
1. a kind of collagen protein powder to conduce to sleep, which is characterized in that it is formed by following raw materials according mixture: r- aminobutyric acid
0.1g~10g, muzao jujube extract 0.1g~12g, Wild jujube seeds extract 0.1g~12g, vitamin B2100ug~10mg and collagen
Albumen powder 99.6999g~65.99g.
2. a kind of collagen protein powder to conduce to sleep as described in claim 1, which is characterized in that the weight of each raw material
Are as follows: muzao jujube extract 0.8g that r- aminobutyric acid 1g that weight content is 20%, weight content are 10%, weight content 10%
Wild jujube seeds extract 0.8g, vitamin B25mg and collagen protein powder 97.4g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711403990.3A CN109953348A (en) | 2017-12-22 | 2017-12-22 | A kind of collagen protein powder to conduce to sleep |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711403990.3A CN109953348A (en) | 2017-12-22 | 2017-12-22 | A kind of collagen protein powder to conduce to sleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109953348A true CN109953348A (en) | 2019-07-02 |
Family
ID=67019290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711403990.3A Withdrawn CN109953348A (en) | 2017-12-22 | 2017-12-22 | A kind of collagen protein powder to conduce to sleep |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109953348A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021156400A1 (en) * | 2020-02-07 | 2021-08-12 | Société des Produits Nestlé S.A. | Sleep dietary supplement |
-
2017
- 2017-12-22 CN CN201711403990.3A patent/CN109953348A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021156400A1 (en) * | 2020-02-07 | 2021-08-12 | Société des Produits Nestlé S.A. | Sleep dietary supplement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101991766B (en) | Medicament for facilitating sleep and preparation method and application thereof | |
| CN105725211A (en) | Food health product for improving sleep and preparation method thereof | |
| CN102335330B (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN102716315B (en) | Kidney yang tonifying health care medicinal liquor and preparation method thereof | |
| CN103251803A (en) | Formula and process of health-assistant wine | |
| CN109820905A (en) | A kind of pharmaceutical composition and its application for treating insomnia | |
| CN101773559A (en) | Chinese medicine preparation for treating insomnia | |
| CN105999130A (en) | Traditional Chinese medicinal composition for treating insomnia, and preparation method thereof | |
| CN101181054A (en) | Health food for improving dormancy | |
| CN109953348A (en) | A kind of collagen protein powder to conduce to sleep | |
| CN105901145A (en) | Sleep comforting pasteurized milk and preparation method thereof | |
| CN102908396B (en) | Chinese medicinal composition for promoting sleeping and preparation method thereof | |
| CN107836938A (en) | A kind of Chinese medicinal pillow for treating infantile convulsion | |
| CN104524464A (en) | Traditional Chinese medicine preparation for treating hyperactivity and preparation method of traditional Chinese medicine preparation | |
| CN108294300A (en) | A kind of tranquilizing the mind dinner powder | |
| CN104706881A (en) | Health product with sleep adjusting function | |
| CN108617824A (en) | A kind of preparation method of ginseng Cranberry sleeping health preserving tea | |
| CN104162005A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN100548348C (en) | The neurasthenic Chinese medicine composition of a kind of orally taken for curing | |
| CN103330912B (en) | Traditional Chinese medicament for treating insomnia | |
| CN104757841A (en) | Traditional Chinese medicine health-care pillow and preparation method thereof | |
| CN104815201B (en) | A kind of healthy medicated wine for treating insomnia | |
| CN104643767A (en) | Drug pillow capable of soothing nerves and aiding sleeping | |
| CN103520412A (en) | Chinese medicinal decoction for treating meniere vertigo | |
| CN107837331A (en) | A kind of Chinese medicine composition for treating insomnia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190702 |